OpenLegislation

Paragraph 1 InterpretationF1

(1)

In this Schedule—

  • “end of trial date” is the date of the conclusion of the trial that is specified in the protocol of a clinical trial and which, in the case of a clinical trial conducted in other countries as well as the United Kingdom, is the end of the date of the trial in all the participating countries;

  • “the new rules” means these Regulations as in force on and after the relevant day;

  • “new rules clinical trial” means a clinical trial which is not an old rules clinical trial;

  • “old committee” means an ethics committee recognised under the old rules that has been abolished or has ceased to operate as an ethics committee for the purposes of these Regulations;

  • “the old rules” means these Regulations as in force immediately before the relevant day;

  • “old rules clinical trial” is to be construed in accordance with paragraph 2(1)(a);

  • “the relevant day” means the day on which this Schedule comes into force.

(2)

Where, by virtue of this Schedule, the old rules continue to apply, regulation 2 of the old rules applies to the interpretation of the old rules, except in so far as it is necessary for regulation 2 of the new rules to apply to their interpretation in order to give effect to a provision of this Schedule (for example, because a new committee is performing functions of an old committee).

(3)

For purposes of this Schedule, “sponsor”, in the context of the old rules, has the meaning given in regulation 3 of the old rules.

(4)

Regulation 53 of the new rules applies to both the new rules and the old rules.

Annotations

Textual amendments

F1

Sch. 14 inserted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 45